Related Experiment Video
Updated: May 20, 2026
08:12
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
Pretransplant MRD: the light is yellow, not red
Alan S Wayne1, Jerald P Radich
1National Cancer Institute; Fred Hutchinson Cancer Research Center.
Blood
|July 14, 2012
Summary
Detecting minimal residual disease (MRD) before stem cell transplants can predict outcomes for children with leukemia. However, MRD does not prevent a cure in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) cases.
Area of Science:
- Hematology
- Pediatric Oncology
- Transplantation Science
Background:
- Minimal residual disease (MRD) detection is a critical factor in assessing treatment efficacy for pediatric leukemias.
- Hematopoietic stem cell transplantation (HSCT) is a curative option for high-risk acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
Discussion:
- The prognostic value of pre-HSCT MRD in pediatric ALL and AML requires careful consideration.
- Understanding the impact of MRD on long-term outcomes post-HSCT is essential for treatment stratification.
Key Insights:
- Detectable MRD before HSCT in pediatric ALL and AML is prognostic for patient outcomes.
- The presence of MRD before HSCT does not preclude successful cure in these pediatric leukemia populations.
Outlook:
- Further research should explore MRD-guided treatment modifications to optimize HSCT protocols.
- Investigating novel therapeutic strategies to eradicate MRD and improve cure rates in pediatric leukemias is warranted.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...